Idiopathic pulmonary fibrosis: Early detection and referral

Respiratory Medicine

Volumn 108, Issue 6, 2014, Pages 819-829

  Oldham, Justin M ^a   Noth, Imre ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

ILD; IPF; Lung transplant; Pulmonary fibrosis

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; PIRFENIDONE; PREDNISONE; OXYGEN; RESPIRATORY TRACT AGENT;

ANOREXIA; BRONCHOSCOPY; COMORBIDITY; DISEASE COURSE; DIZZINESS; DYSPEPSIA; EARLY DIAGNOSIS; FATIGUE; FIBROSING ALVEOLITIS; HEALTH CARE ACCESS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; NAUSEA; OXYGEN THERAPY; PATHOLOGIST; PATIENT CARE; PATIENT REFERRAL; PHOTOSENSITIVITY; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; RADIOLOGIST; RASH; REVIEW; SURVIVAL; THORAX RADIOGRAPHY; TREATMENT INDICATION; AGED; BIOPSY; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MIDDLE AGED; PATHOLOGY; PHYSICAL EXAMINATION; PROCEDURES;

AGED; BIOPSY; BRONCHOSCOPY; CLINICAL LABORATORY TECHNIQUES; EARLY DIAGNOSIS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; LUNG TRANSPLANTATION; MIDDLE AGED; OXYGEN; PATIENT CARE TEAM; PHYSICAL EXAMINATION; REFERRAL AND CONSULTATION; RESPIRATORY FUNCTION TESTS; RESPIRATORY SYSTEM AGENTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84902244179     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.03.008     Document Type: Review

References (108)

1. T.E. King Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases Am J Respir Crit Care Med 172 2005 268 279
2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am J Respir Crit Care Med 165 2002 277 304
3. J.A. Bjoraker, J.H. Ryu, and M.K. Edwin et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 157 1998 199 203
4. G. Raghu, H.R. Collard, and J.J. Egan et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 2011 788 824
5. J. De Vries, B.L. Kessels, and M. Drent Quality of life of idiopathic pulmonary fibrosis patients Eur Respir J 17 2001 954 961
6. H. Tomioka, K. Imanaka, K. Hashimoto, and H. Iwasaki Health-related quality of life in patients with idiopathic pulmonary fibrosis-cross-sectional and longitudinal study Intern Med 46 2007 1533 1542
7. S.D. Nathan, O.A. Shlobin, and N. Weir et al. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium Chest 140 2011 221 229
8. L. Nalysnyk, J. Cid-Ruzafa, P. Rotella, and D. Esser Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature Eur Respir Rev 21 2012 355 361
9. E.R. Fernandez Perez, C.E. Daniels, and D.R. Schroeder et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study Chest 137 2010 129 137
10. G. Raghu, D. Weycker, J. Edelsberg, W.Z. Bradford, and G. Oster Incidence and prevalence of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 174 2006 810 816
11. J. Gribbin, R.B. Hubbard, I. Le Jeune, C.J. Smith, J. West, and L.J. Tata Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK Thorax 61 2006 980 985
12. V. Navaratnam, K.M. Fleming, and J. West et al. The rising incidence of idiopathic pulmonary fibrosis in the U.K Thorax 66 2011 462 467
13. D.W. Mapel, W.C. Hunt, R. Utton, K.B. Baumgartner, J.M. Samet, and D.B. Coultas Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts Thorax 53 1998 469 476
14. G. Raghu Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011 Eur Respir J 37 2011 743 746
15. G. Schoenheit, I. Becattelli, and A.H. Cohen Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients Chron Respir Dis 8 2011 225 231
16. H.R. Collard, G. Tino, and P.W. Noble et al. Patient experiences with pulmonary fibrosis Respir Med 101 2007 1350 1354
17. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am J Respir Crit Care Med 161 2000 646 664
18. R.G. Crystal, J.D. Fulmer, W.C. Roberts, M.L. Moss, B.R. Line, and H.Y. Reynolds Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects Ann Intern Med 85 1976 769 788
19. D. Fioret, R.L. Perez, and J. Roman Management of idiopathic pulmonary fibrosis Am J Med Sci 341 2011 450 453
20. A.L. Key, K. Holt, A. Hamilton, J.A. Smith, and J.E. Earis Objective cough frequency in idiopathic pulmonary fibrosis Cough 6 2010 4
21. K.B. Baumgartner, J.M. Samet, C.A. Stidley, T.V. Colby, and J.A. Waldron Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis Am J Respir Crit Care Med 155 1997 242 248
22. T. Enomoto, J. Usuki, A. Azuma, T. Nakagawa, and S. Kudoh Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis Chest 123 2003 2007 2011
23. V.S. Taskar, and D.B. Coultas Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc 3 2006 293 298
24. G. Raghu, T.D. Freudenberger, and S. Yang et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis Eur Respir J 27 2006 136 142
25. R.W. Tobin, C.E. Pope 2nd, C.A. Pellegrini, M.J. Emond, J. Sillery, and G. Raghu Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 158 1998 1804 1808
26. I. Noth, S.M. Zangan, and R.V. Soares et al. Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis Eur Respir J 39 2012 344 351
27. N.J. Awadalla, A. Hegazy, R.A. Elmetwally, and I. Wahby Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Egypt: a multicenter case-control study Int J Occup Environ Med 3 2012 107 116
28. K. Iwai, T. Mori, N. Yamada, M. Yamaguchi, and Y. Hosoda Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure Am J Respir Crit Care Med 150 1994 670 675
29. R. Hubbard, S. Lewis, K. Richards, I. Johnston, and J. Britton Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis Lancet 347 1996 284 289
30. Y. Miyake, S. Sasaki, and T. Yokoyama et al. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan Ann Occup Hyg 49 2005 259 265
31. U. Hodgson, T. Laitinen, and P. Tukiainen Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland Thorax 57 2002 338 342
32. C. Garcia-Sancho, I. Buendia-Roldan, and M.R. Fernandez-Plata et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis Respir Med 105 2011 1902 1907
33. T.E. King Jr., J.A. Tooze, M.I. Schwarz, K.R. Brown, and R.M. Cherniack Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model Am J Respir Crit Care Med 164 2001 1171 1181
34. W.W. Douglas, J.H. Ryu, and D.R. Schroeder Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival Am J Respir Crit Care Med 161 2000 1172 1178
35. V. Cottin, and J.-F. Cordier Subclinical interstitial lung disease: no place for crackles? Am J Respir Crit Care Med 186 2012 289
36. V. Cottin, and J.F. Cordier Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis? Eur Respir J 40 2012 519 521
37. I.D. Johnston, R.J. Prescott, J.C. Chalmers, and R.M. Rudd British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society Thorax 52 1997 38 44
38. J.S. Lee, E.J. Kim, and K.L. Lynch et al. Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis Respir Med 107 2013 249 255
39. A. Moeller, S.E. Gilpin, and K. Ask et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 179 2009 588 594
40. A. Yokoyama, K. Kondo, and M. Nakajima et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis Respirology 11 2006 164 168
41. J.D. Herazo-Maya, I. Noth, and S.R. Duncan et al. Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis Sci Transl Med 5 2013 205ra136
42. T.E. King Jr., M.I. Schwarz, and K. Brown et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality Am J Respir Crit Care Med 164 2001 1025 1032
43. S.L. Schmidt, N. Tayob, and M.K. Han et al. Predicting pulmonary fibrosis disease course from past trends in pulmonary function Chest 145 3 March 2014 579 585
44. T. Akagi, T. Matsumoto, and T. Harada et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis Respir Med 103 2009 1209 1215
45. J.F. Aduen, D.A. Zisman, and S.I. Mobin et al. Retrospective study of pulmonary function tests in patients presenting with isolated reduction in single-breath diffusion capacity: implications for the diagnosis of combined obstructive and restrictive lung disease Mayo Clin Proc 82 2007 48 54
46. P.I. Latsi, R.M. du Bois, and A.G. Nicholson et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends Am J Respir Crit Care Med 168 2003 531 537
47. L. Richeldi, C.J. Ryerson, and J.S. Lee et al. Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis Thorax 67 2012 407 411
48. C.J. Zappala, P.I. Latsi, and A.G. Nicholson et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis Eur Respir J 35 2010 830 836
49. H.R. Collard, T.E. King Jr., B.B. Bartelson, J.S. Vourlekis, M.I. Schwarz, and K.K. Brown Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 168 2003 538 542
50. R.M. du Bois, D. Weycker, and C. Albera et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference Am J Respir Crit Care Med 183 2011 1231 1237
51. M.L. Guerry-Force, N.L. Muller, and J.L. Wright et al. A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia, and small airways disease Am Rev Respir Dis 135 1987 705 712
52. N.L. Muller, M.L. Guerry-Force, and C.A. Staples et al. Differential diagnosis of bronchiolitis obliterans with organizing pneumonia and usual interstitial pneumonia: clinical, functional, and radiologic findings Radiology 162 1987 151 156
53. J.R. Mathieson, J.R. Mayo, C.A. Staples, and N.L. Muller Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography Radiology 171 1989 111 116
54. G.R. Epler, T.C. McLoud, E.A. Gaensler, J.P. Mikus, and C.B. Carrington Normal chest roentgenograms in chronic diffuse infiltrative lung disease N Engl J Med 298 1978 934 939
55. H. Sumikawa, T. Johkoh, and T.V. Colby et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival Am J Respir Crit Care Med 177 2008 433 439
56. K.R. Flaherty, E.L. Thwaite, and E.A. Kazerooni et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications Thorax 58 2003 143 148
57. G. Raghu, Y.N. Mageto, D. Lockhart, R.A. Schmidt, D.E. Wood, and J.D. Godwin The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study Chest 116 1999 1168 1174
58. K.R. Flaherty, J.A. Mumford, and S. Murray et al. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia Am J Respir Crit Care Med 168 2003 543 548
59. G.W. Hunninghake, M.B. Zimmerman, and D.A. Schwartz et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 164 2001 193 196
60. ACR practice guideline for the performance of high-resolution computed tomography (HRCT) of the lungs in adults 2010 at http://www.acr.org/∼/media/ ACR/Documents/PGTS/guidelines/HRCT-Lungs.pdf
61. K.C. Meyer, G. Raghu, and R.P. Baughman et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease Am J Respir Crit Care Med 185 2012 1004 1014
62. J.H. Park, D.K. Kim, and D.S. Kim et al. Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia Eur J Cardiothorac Surg 31 2007 1115 1119
63. J.P. Utz, J.H. Ryu, and W.W. Douglas et al. High short-term mortality following lung biopsy for usual interstitial pneumonia Eur Respir J 17 2001 175 179
64. Q. Luo, Q. Han, X. Chen, J. Xie, L. Wu, and R. Chen The diagnosis efficacy and safety of video-assisted thoracoscopy surgery (VATS) in undefined interstitial lung diseases: a retrospective study J Thorac Dis 5 2013 283 288
65. K.R. Flaherty, W.D. Travis, and T.V. Colby et al. Histopathologic variability in usual and nonspecific interstitial pneumonias Am J Respir Crit Care Med 164 2001 1722 1727
66. A.L. Katzenstein, S. Mukhopadhyay, and J.L. Myers Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases Hum Pathol 39 2008 1275 1294
67. K.R. Flaherty, G.B. Toews, and W.D. Travis et al. Clinical significance of histological classification of idiopathic interstitial pneumonia Eur Respir J 19 2002 275 283
68. G. Raghu, K.J. Anstrom, T.E. King Jr., J.A. Lasky, and F.J. Martinez Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis N Engl J Med 366 2012 1968 1977
69. D.W. Visscher, and J.L. Myers Histologic spectrum of idiopathic interstitial pneumonias Proc Am Thorac Soc 3 2006 322 329
70. K.R. Flaherty, T.E. King Jr., and G. Raghu et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 170 2004 904 910
71. K.R. Flaherty, A.C. Andrei, and T.E. King Jr. et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med 175 2007 1054 1060
72. D.J. Lamas, S.M. Kawut, E. Bagiella, N. Philip, S.M. Arcasoy, and D.J. Lederer Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study Am J Respir Crit Care Med 184 2011 842 847
73. Y. Ma, C.K. Seneviratne, and M. Koss Idiopathic pulmonary fibrosis and malignancy Curr Opin Pulm Med 7 2001 278 282
74. S.D. Nathan, A. Basavaraj, and C. Reichner et al. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis Respir Med 104 2010 1035 1041
75. L.H. Lancaster, W.R. Mason, and J.A. Parnell et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis Chest 136 2009 772 778
76. V. Cottin, H. Nunes, and P.Y. Brillet et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Eur Respir J 26 2005 586 593
77. A.F. Shorr, J.L. Wainright, C.S. Cors, C.J. Lettieri, and S.D. Nathan Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant Eur Respir J 30 2007 715 721
78. A.A. Akhtar, M.A. Ali, and R.P. Smith Depression in patients with idiopathic pulmonary fibrosis Chron Respir Dis 10 2013 127 133
79. J.S. Lee, J.H. Ryu, and B.M. Elicker et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 2011 1390 1394
80. C. Mermigkis, I. Bouloukaki, and K.M. Antoniou et al. CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep? Sleep Breath 17 2013 1137 1143
81. D.A. Zisman, M. Schwarz, K.J. Anstrom, H.R. Collard, K.R. Flaherty, and G.W. Hunninghake A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis N Engl J Med 363 2010 620 628
82. T.E. King Jr., K.K. Brown, and G. Raghu et al. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 2011 92 99
83. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group Ann Intern Med 93 1980 391 398
84. A. Holland, and C. Hill Physical training for interstitial lung disease Cochrane Database Syst Rev 2008 CD006322
85. A.E. Holland, C.J. Hill, I. Glaspole, N. Goh, and C.F. McDonald Predictors of benefit following pulmonary rehabilitation for interstitial lung disease Respir Med 106 2012 429 435
86. S. Nagai, M. Kitaichi, and K. Hamada et al. Hospital-based historical cohort study of 234 histologically proven Japanese patients with IPF Sarcoidosis Vasc Diffuse Lung Dis 16 1999 209 214
87. M. Demedts, J. Behr, and R. Buhl et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis N Engl J Med 353 2005 2229 2242
88. J. Behr, K. Maier, B. Degenkolb, F. Krombach, and C. Vogelmeier Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression Am J Respir Crit Care Med 156 1997 1897 1901
89. H. Taniguchi, M. Ebina, and Y. Kondoh et al. Pirfenidone in idiopathic pulmonary fibrosis Eur Respir J 35 2010 821 829
90. P.W. Noble, C. Albera, and W.Z. Bradford et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials Lancet 377 2011 1760 1769
91. A. Azuma, T. Nukiwa, and E. Tsuboi et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 171 2005 1040 1047
92. P. Spagnolo, C. Del Giovane, and F. Luppi et al. Non-steroid agents for idiopathic pulmonary fibrosis Cochrane Database Syst Rev 2010 CD003134
93. C. Jiang, H. Huang, J. Liu, Y. Wang, Z. Lu, and Z. Xu Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials PLoS One 7 2012 e47024
94. H. Kubo, K. Nakayama, and M. Yanai et al. Anticoagulant therapy for idiopathic pulmonary fibrosis Chest 128 2005 1475 1482
95. I. Noth, K.J. Anstrom, and S.B. Calvert et al. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 186 2012 88 95
96. K.E. Bendstrup, J. Gram, and J.I. Jensen Effect of inhaled heparin on lung function and coagulation in healthy volunteers Eur Respir J 19 2002 606 610
97. E. Bendstrup, and O. Hilberg Is warfarin the right anticoagulant in idiopathic pulmonary fibrosis? Am J Respir Crit Care Med 186 2012 693 author reply -4
98. G. Thabut, H. Mal, and Y. Castier et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis J Thorac Cardiovasc Surg 126 2003 469 475
99. Unilateral lung transplantation for pulmonary fibrosis. Toronto Lung Transplant Group N Engl J Med 314 1986 1140 1145
100. Organ Procurement and Transplantation Network (OPTN). 2012 at http://optn.transplant.hrsa.gov.
101. S.D. Nathan, O.A. Shlobin, S. Ahmad, N.A. Burton, S.D. Barnett, and E. Edwards Comparison of wait times and mortality for idiopathic pulmonary fibrosis patients listed for single or bilateral lung transplantation J Heart Lung Transplant 29 2010 1165 1171
102. J.D. Christie, L.B. Edwards, and A.Y. Kucheryavaya et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012 J Heart Lung Transplant 31 2012 1073 1086
103. G. Thabut, J.D. Christie, and P. Ravaud et al. Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis Ann Intern Med 151 2009 767 774
104. D.P. Mason, M.E. Brizzio, and J.M. Alster et al. Lung transplantation for idiopathic pulmonary fibrosis Ann Thorac Surg 84 2007 1121 1128
105. N.C. De Oliveira, S. Osaki, J. Maloney, R.D. Cornwell, and K.C. Meyer Lung transplant for interstitial lung disease: outcomes for single versus bilateral lung transplantation Interact Cardiovasc Thorac Surg 14 2012 263 267
106. T.J. George, G.J. Arnaoutakis, and A.S. Shah Lung transplant in idiopathic pulmonary fibrosis Arch Surg 146 2011 1204 1209
107. D. Keating, B. Levvey, and T. Kotsimbos et al. Lung transplantation in pulmonary fibrosis: challenging early outcomes counterbalanced by surprisingly good outcomes beyond 15 years Transplant Proc 41 2009 289 291
108. J.B. Orens, M. Estenne, and S. Arcasoy et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation J Heart Lung Transplant 25 2006 745 755